Korro Bio Stock (NASDAQ:KRRO)


ForecastChart

Previous Close

$13.83

52W Range

$10.29 - $98.00

50D Avg

$13.50

200D Avg

$30.83

Market Cap

$128.37M

Avg Vol (3M)

$136.08K

Beta

2.43

Div Yield

-

KRRO Company Profile


Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

112

IPO Date

Oct 03, 2019

Website

KRRO Performance